Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MACIAS, Juan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapyPINEDA, Juan A; MACIAS, Juan.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 4, pp 417-419, issn 0305-7453, 3 p.Article

Latest pharmacotherapy options for treating hepatitis C in HIV-infected patientsMACIAS, Juan; NEUKAM, Karin; MERCHANTE, Nicolás et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 13, pp 1837-1848, issn 1465-6566, 12 p.Article

Incidence and natural history of hepatitis E virus coinfection among HIV-infected patientsPINEDA, Juan A; CIFUENTES, Celia; PARRA, Manuel et al.AIDS (London). 2014, Vol 28, Num 13, pp 1931-1937, issn 0269-9370, 7 p.Article

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patientsMACIAS, Juan; GONZALEZ, Juan; BURGOS, Ángel et al.AIDS (London). 2014, Vol 28, Num 9, pp 1279-1287, issn 0269-9370, 9 p.Article

Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral RibavirinNEUKAM, Karin; BARREIRO, Pablo; MACIAS, Juan et al.Clinical infectious diseases. 2013, Vol 57, Num 3, pp 465-468, issn 1058-4838, 4 p.Article

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometryNEUKAM, Karin; RECIO, Eva; CAMACHO, Angela et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 7, pp 801-807, issn 0954-691X, 7 p.Article

Vitamin D Receptor Gene Haplotypes and Susceptibility to HIV-1 Infection in Injection Drug UsersDE LA TORRE, Manuel Sanchez; TORRES, Carmen; NIETO, Gema et al.The Journal of infectious diseases. 2008, Vol 197, Num 3, pp 405-410, issn 0022-1899, 6 p.Article

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapyPINEDA, Juan A; GARCIA-GARCIA, José A; CAMACHO, Angela et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 3, pp 622-630, issn 0270-9139, 9 p.Article

Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from spain in the era of highly active antiretroviral therapyDE LA ROSA, Rafael; PINEDA, Juan A; DELGADO, Juan et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 762-767, issn 0095-1137Article

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/ Hepatitis C Virus―Coinfected Patients With Compensated CirrhosisMIRA, José A; RIVERO-JUAREZ, Antonio; GEA, Isabel et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1646-1653, issn 1058-4838, 8 p.Article

HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infectionNEUKAM, Karin; GARCIA-REY, Silvia; PINEDA, Juan A et al.Antiviral research. 2012, Vol 95, Num 3, pp 212-215, issn 0166-3542, 4 p.Article

Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patientsPINEDA, Juan A; CARUZ, Antonio; DI LELLO, Federico A et al.AIDS (London). 2011, Vol 25, Num 11, pp 1415-1420, issn 0269-9370, 6 p.Article

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations : effect of hepatitis virus co-infection and pre-existing fibrosisMACIAS, Juan; ORIHUELA, Francisco; ABDEL-KADER, Laila et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 1, pp 178-183, issn 0305-7453, 6 p.Article

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfectionMACIAS, Juan; JAPON, Miguel A; PINEDA, Juan A et al.The Journal of infectious diseases. 2005, Vol 192, Num 9, pp 1566-1576, issn 0022-1899, 11 p.Article

Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatmentMIRA, Jose A; LOZANO, Fernando; GOMEZ-MATEOS, Jesus et al.Antiviral therapy (London). 2004, Vol 9, Num 4, pp 511-517, issn 1359-6535, 7 p.Article

Necrotizing granulomatous vasculitis in advanced HIV infectionGARCIA-GARCIA, Jose A; MACIAS, Juan; CASTELLANOS, Victor et al.The Journal of infection. 2003, Vol 47, Num 4, pp 333-335, issn 0163-4453, 3 p.Article

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patientsDE LA ROSA, Rafael; PINEDA, Juan A; DELGADO, Juan et al.Clinical infectious diseases. 2001, Vol 32, Num 4, pp 633-635, issn 1058-4838Article

Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infectionBIASIN, Mara; SIRONI, Manuela; TRABATTONI, Daria et al.AIDS (London). 2013, Vol 27, Num 11, pp 1697-1706, issn 0269-9370, 10 p.Article

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patientsMACIAS, Juan; CAMACHO, Angela; MANCEBO, María et al.AIDS (London). 2013, Vol 27, Num 16, pp 2541-2549, issn 0269-9370, 9 p.Article

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infectionNEUKAM, Karin; CARUZ, Antonio; MACIAS, Juan et al.AIDS (London). 2013, Vol 27, Num 17, pp 2715-2724, issn 0269-9370, 10 p.Article

Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infectionSIRONI, Manuela; BIASIN, Mara; CARUZ, Antonio et al.AIDS (London). 2012, Vol 26, Num 11, pp 1443-1445, issn 0269-9370, 3 p.Article

Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patientsRIVERO-JUAREZ, Antonio; MIRA, Jose A; PEREZ-CAMACHO, Inés et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 6, pp 1351-1353, issn 0305-7453, 3 p.Article

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirinMACIAS, Juan; DEL VALLE, José; TORRE-CISNEROS, Julián et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 10, pp 2204-2211, issn 0305-7453, 8 p.Article

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patientsVERGARA, Salvador; MACIAS, Juan; MIRA, José A et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 1, pp 87-91, issn 0305-7453, 5 p.Article

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapyMACIAS, Juan; PALOMARES, José C; MIRA, José A et al.The Journal of infection. 2005, Vol 51, Num 3, pp 195-200, issn 0163-4453, 6 p.Article

  • Page / 3